Costa Rican Monte Crisol (Coffea arabica)

Costa Rican Monte Crisol is an Arabica coffee cultivar (Coffea arabica) grown in Costa Rica, valued for its distinct cup profile shaped by regional terroir rather than documented therapeutic compounds. Like all Arabica varieties, it contains caffeine and chlorogenic acids, but no clinical research exists isolating health effects specific to this cultivar.

Origin & History

Costa Rican Monte Crisol is a premium coffee cultivar variant of Coffea arabica, grown at 1,200-1,800 meters elevation in Costa Rica's West Central Valley by the Coopepalmares cooperative. It undergoes washed processing (eco-pulping and sun-drying) and is known for its sensory qualities including blueberry topnotes, chocolate, and orange flavors.

Historical & Cultural Context

No historical or traditional medicinal uses of Monte Crisol are documented in any systems. Sources emphasize only modern gourmet coffee production and flavor profiles.

Health Benefits

• No clinical health benefits documented - research focuses exclusively on sensory/gastronomic attributes
• No human trials or meta-analyses available for this specific cultivar
• No biomedical evidence presented in available sources
• No active compound concentrations or mechanisms studied
• No traditional medicinal uses recorded

How It Works

As a Coffea arabica cultivar, Monte Crisol contains caffeine, which antagonizes adenosine A1 and A2A receptors in the central nervous system, reducing fatigue signaling. Chlorogenic acids present in green coffee beans inhibit glucose-6-phosphatase and modulate AMPK pathways, potentially influencing glucose metabolism. However, no studies have measured the specific concentrations of these compounds in Monte Crisol beans or established mechanisms unique to this cultivar.

Scientific Research

No clinical trials, RCTs, or meta-analyses on Monte Crisol exist in the available sources. No PubMed PMIDs are provided, and the research dossier explicitly states there is no clinical evidence, human trials, or biomedical data for this coffee cultivar.

Clinical Summary

No clinical trials, observational studies, or meta-analyses exist specifically examining Costa Rican Monte Crisol as a health intervention. Available literature on this cultivar is restricted to sensory evaluation, agronomic performance, and specialty coffee grading contexts. Any health inferences would need to be extrapolated cautiously from general Coffea arabica research, which itself varies significantly by roast level, preparation method, and bean origin. The absence of biomedical data means no evidence-based dosage, efficacy claim, or therapeutic indication can be assigned to this cultivar.

Nutritional Profile

Costa Rican Monte Crisol (Coffea arabica) shares the baseline nutritional composition typical of specialty Arabica coffee beans from high-altitude Central American origins. Raw green bean composition (per 100g dry weight): moisture 10–12g, crude protein 10–13g (primarily non-digestible storage proteins; glutelin and albumin fractions dominant), total lipids 15–17g (predominantly triglycerides with linoleic acid ~46%, palmitic acid ~30%, oleic acid ~8%, and stearic acid ~8% of fatty acid profile; coffee oil also contains diterpenes cafestol and kahweol at ~0.2–0.8% of lipid fraction combined), total carbohydrates 58–65g (sucrose 6–9g dominant soluble sugar pre-roast; polysaccharides including galactomannans ~20g and arabinogalactans ~8g contributing to body and mouthfeel), dietary fiber (insoluble cellulose/hemicellulose) ~35–40g in green bean, largely degraded through roasting. Chlorogenic acids (CGAs): as a high-altitude Costa Rican Arabica, estimated total CGA content 6–9g per 100g green bean, with 5-caffeoylquinic acid (5-CQA) as the dominant isomer (~3.5–5g/100g); CGAs degrade 50–80% during medium-to-dark roasting. Caffeine content: Arabica species characteristic range 0.8–1.4g per 100g green bean; brewed cup yield approximately 80–120mg per 200ml depending on preparation method. Trigonelline: ~0.6–1.2g per 100g green bean; partially converts to niacin (vitamin B3) during roasting, contributing ~0.5–2mg niacin per brewed cup. Melanoidins (post-roast): formed during Maillard reaction, comprising 25–30% of roasted bean dry weight; act as dietary fiber analogs and carry antioxidant capacity. Mineral content per 100g roasted ground coffee: potassium ~1,600–2,100mg (primary mineral), magnesium ~200–230mg, phosphorus ~140–160mg, calcium ~120–140mg, manganese ~1.5–2.5mg, copper ~0.3–0.5mg, iron ~3–5mg (low bioavailability due to chlorogenic acid chelation). B vitamins in brewed cup: niacin (B3) 0.5–2mg (roasting-derived from trigonelline), riboflavin (B2) trace ~0.01mg. Antioxidant capacity (ORAC): brewed Arabica specialty coffee approximately 2,780–15,000 µmol TE per 100ml depending on roast and brewing; Monte Crisol's specific terroir (volcanic mineral-rich soils, ~1,400–1,800m altitude) likely supports upper-range CGA accumulation in green beans, though cultivar-specific quantification is not published. Bioavailability notes: CGAs show 33% absorption in small intestine; remainder fermented by colonic microbiota into hydroxycinnamic acid metabolites; cafestol and kahweol are removed by paper filtration but retained in French press/espresso preparations; caffeine bioavailability approaches 100% from gastrointestinal tract.

Preparation & Dosage

No clinically studied dosage ranges documented. Sources describe only culinary use as brewed coffee without standardization or therapeutic dosing. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Not applicable - no biomedical applications studied

Safety & Interactions

As a Coffea arabica product, Monte Crisol coffee carries the standard safety profile of caffeinated beverages, including risk of insomnia, increased heart rate, and elevated blood pressure at high intake levels. Caffeine interacts with adenosine-based medications, certain antidepressants (particularly MAOIs), and anticoagulants such as warfarin by altering their metabolism via CYP1A2 enzyme pathways. Pregnant individuals are advised to limit total caffeine intake to under 200 mg per day per major obstetric guidelines, as higher intake is associated with adverse fetal outcomes. No cultivar-specific safety concerns for Monte Crisol have been identified in available literature.